RadNet (NASDAQ:RDNT) Announces Quarterly Earnings Results

RadNet (NASDAQ:RDNTGet Free Report) posted its quarterly earnings data on Thursday. The medical research company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.01, Zacks reports. RadNet had a negative net margin of 0.25% and a positive return on equity of 4.29%. The firm had revenue of $477.10 million for the quarter, compared to the consensus estimate of $459.42 million. RadNet updated its FY 2025 guidance to EPS.

RadNet Price Performance

NASDAQ:RDNT traded down $3.25 during trading hours on Friday, hitting $54.35. The company’s stock had a trading volume of 1,557,750 shares, compared to its average volume of 806,843. The business’s 50-day moving average is $65.77 and its two-hundred day moving average is $69.04. The company has a market capitalization of $4.02 billion, a PE ratio of -776.75 and a beta of 1.79. RadNet has a 52-week low of $37.04 and a 52-week high of $93.65. The company has a debt-to-equity ratio of 0.89, a quick ratio of 2.16 and a current ratio of 2.16.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on RDNT shares. Barclays lowered their target price on RadNet from $85.00 to $74.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 22nd. Truist Financial reissued a “buy” rating and set a $88.00 target price (down previously from $94.00) on shares of RadNet in a research note on Wednesday, January 22nd. Finally, Jefferies Financial Group dropped their target price on RadNet from $100.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, January 15th. One investment analyst has rated the stock with a sell rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, RadNet has a consensus rating of “Moderate Buy” and an average target price of $75.50.

Get Our Latest Report on RadNet

RadNet Company Profile

(Get Free Report)

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.

See Also

Earnings History for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.